Glycolipids and analogues thereof as antigens for NKT cells
US8586051B2 · kind B2 · utility
0Cited by
6References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2012 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Mar 15, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to immunogenic compounds which serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.